Hospitalization rates and discharge status in multiple sclerosis
- PMID: 23766908
- PMCID: PMC3666201
- DOI: 10.1155/2013/436929
Hospitalization rates and discharge status in multiple sclerosis
Abstract
Management of multiple sclerosis (MS) has shifted from supportive to disease modifying therapy. Considering the increasingly widespread adoption of this approach in managing MS patients, we hypothesized that hospitalizations and surrogates of disease-related complications should have declined during the last decade. Methods. Using the Nationwide Inpatient Sample, hospitalizations for MS and associated secondary diagnoses and procedures as well as discharge status were examined. Time trends were examined for different age cohorts focusing on the period from 2001 to 2010. Results. During the preceding decade, annual hospitalizations for MS increased by 40%, with stable rates in all age groups except geriatric patients, who accounted for a significantly higher fraction of admissions. Nursing home transfers as a surrogate marker of disability remained unchanged for all age groups. Similarly, urinary tract infections, the need for skin debridement, or gastrostomy tube placement did not vary during the decade. Conclusion. During a time of increased adoption of disease modifying therapy, MS-related hospitalizations continued to increase and surrogate measures of disability in admitted patients remained stable, demonstrating the still significant impact of the disease on affected individuals.
Figures
Similar articles
-
Incidence, admission rates, and economic burden of pediatric emergency department visits for urinary tract infection: data from the nationwide emergency department sample, 2006 to 2011.J Pediatr Urol. 2015 Oct;11(5):246.e1-8. doi: 10.1016/j.jpurol.2014.10.005. Epub 2015 Feb 7. J Pediatr Urol. 2015. PMID: 26005017
-
Pediatric hospitalizations for upper urinary tract calculi: Epidemiological and treatment trends in the United States, 2001-2014.J Pediatr Urol. 2018 Feb;14(1):13.e1-13.e6. doi: 10.1016/j.jpurol.2017.09.001. Epub 2017 Sep 7. J Pediatr Urol. 2018. PMID: 28966022
-
Hospital Transfer Rates Among US Nursing Home Residents With Advanced Illness Before and After Initiatives to Reduce Hospitalizations.JAMA Intern Med. 2020 Mar 1;180(3):385-394. doi: 10.1001/jamainternmed.2019.6130. JAMA Intern Med. 2020. PMID: 31886827 Free PMC article.
-
Mitoxantrone: a review of its use in multiple sclerosis.CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010. CNS Drugs. 2004. PMID: 15089110 Review.
-
Rituximab for relapsing-remitting multiple sclerosis.Cochrane Database Syst Rev. 2013 Dec 6;(12):CD009130. doi: 10.1002/14651858.CD009130.pub3. Cochrane Database Syst Rev. 2013. PMID: 24310855 Review.
Cited by
-
Readmission Rates in Patients With Multiple Sclerosis: A Nationwide Cohort Study.Int J MS Care. 2022 Sep-Oct;24(5):218-223. doi: 10.7224/1537-2073.2021-089. Epub 2022 May 3. Int J MS Care. 2022. PMID: 36090236 Free PMC article.
-
Potentially preventable hospitalizations and use of preventive services among people with multiple sclerosis: Large cohort study, USA.Mult Scler Relat Disord. 2022 Dec;68:104105. doi: 10.1016/j.msard.2022.104105. Epub 2022 Aug 11. Mult Scler Relat Disord. 2022. PMID: 36031692 Free PMC article.
-
Association of multiple sclerosis with mortality in sepsis: a population-level analysis.J Intensive Care. 2022 Jul 25;10(1):36. doi: 10.1186/s40560-022-00628-1. J Intensive Care. 2022. PMID: 35879778 Free PMC article.
-
A home-based comprehensive care model in patients with Multiple Sclerosis: A study pre-protocol.F1000Res. 2015 Sep 18;4:872. doi: 10.12688/f1000research.7040.1. eCollection 2015. F1000Res. 2015. PMID: 26673815 Free PMC article.
-
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.J Neurol. 2014 Sep;261(9):1781-8. doi: 10.1007/s00415-014-7395-7. Epub 2014 Jun 28. J Neurol. 2014. PMID: 24972678 Free PMC article. Clinical Trial.
References
-
- Pittock SJ, Mayr WT, McClelland RL, et al. Disability profile of MS did not change over 10 years in a population-based prevalence cohort. Neurology. 2004;62(4):601–606. - PubMed
-
- Pittock SJ, Mayr WT, McClelland RL, et al. Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology. 2004;62(1):51–59. - PubMed
-
- Myhr KM, Riise T, Vedeler C, et al. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Multiple Sclerosis. 2001;7(1):59–65. - PubMed
-
- Bakke A, Myhr KM, Gronning M, Nyland H. Bladder, bowel and sexual dysfunction in patients with multiple sclerosis—a cohort study. Scandinavian Journal of Urology and Nephrology, Supplement. 1996;179:61–66. - PubMed
-
- Hennessey A, Robertson NP, Swingler R, Compston DAS. Urinary, faecal and sexual dysfunction in patients with multiple sclerosis. Journal of Neurology. 1999;246(11):1027–1032. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources